Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China. The company's product pipelines include Tifcemalimab, an anti- B and T lymphocyte attenuator mAB which is in phase III clinical trial to treat lung cancer and lymphocyte; Roconkibart, an anti-interleukin-17A monoclonal antibody which is in phase III clinical trial to treat psoriatic and spondylitis; JS001sc, a subcutaneous injection which is...
Industry: Biotechnology
Sector: Healthcare
Phone: 86 21 6105 8800
Fax: 86 21 6175 7377
Address:
Building 7, 15F No. 6, Pingjiaqiao Road Pudong New Area, Shanghai, China
